Age-related macular degeneration, a deterioration of the central portion of the retina, is the
chief cause of severe and irreversible loss of vision in developed countries. 1, 2 There is no …

The eye has an environment that is specific unto itself in terms of pharmacokinetics: the
inner and outer blood–retinal barriers separate the retina and the vitreous from the systemic …

Purpose: To evaluate the potential of photodynamic therapy (PDT) using benzoporphyrin
derivative (BPD) for occlusion of subretinal neovascular membranes, the authors studied …

PURPOSE: To examine combined photodynamic therapy (PDT) with verteporfin and
intravitreal triamcinolone acetonide for choroidal neovascularization (CNV) secondary to …

Abstract· Background: Conventional photocoagulation of subfoveal choroidal
neovascularization (CNV) is often accompanied by visual loss due to thermal damage to …

Vitreoretinal diseases involving age-related macular degeneration (AMD) are refractory to
most topical or systemic drugs. The retina and the vitreous cavity have a unique position …

In 1875, Pagenstecher and Gentll provided the first description of age-related maculopathy
(ARM). Nowadays, hundred and twenty years after the first description, ARM is one of the …

Purpose To present visual acuity (VA) and related findings from patients enrolled in one of
the Submacular Surgery Trials (SST) evaluating surgical removal versus observation of …

Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in
the USA. Laser photocoagulation of choroidal neovascular membranes (CNVMs) in …

Age-related macular degeneration (AMD) is a common macular disease affecting elderly
people in the Western world. It is characterised by the appearance of drusen in the macula …